Bécouarn, Y., Senesse, P., Thézenas, S., Boucher, E., Adenis, A., Cany, L., . . . Ychou, M. (2007). A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: A study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer. Annals of oncology, 18(12), 2000. https://doi.org/10.1093/annonc/mdm379
Chicago-Zitierstil (17. Ausg.)Bécouarn, Y., et al. "A Randomized Phase II Trial Evaluating Safety and Efficacy of an Experimental Chemotherapy Regimen (irinotecan + Oxaliplatin, IRINOX) and Two Standard Arms (LV5 FU2 + Irinotecan or LV5 FU2 + Oxaliplatin) in First-line Metastatic Colorectal Cancer: A Study of the Digestive Group of the Fédération Nationale Des Centres De Lutte Contre Le Cancer." Annals of Oncology 18, no. 12 (2007): 2000. https://doi.org/10.1093/annonc/mdm379.
MLA-Zitierstil (9. Ausg.)Bécouarn, Y., et al. "A Randomized Phase II Trial Evaluating Safety and Efficacy of an Experimental Chemotherapy Regimen (irinotecan + Oxaliplatin, IRINOX) and Two Standard Arms (LV5 FU2 + Irinotecan or LV5 FU2 + Oxaliplatin) in First-line Metastatic Colorectal Cancer: A Study of the Digestive Group of the Fédération Nationale Des Centres De Lutte Contre Le Cancer." Annals of Oncology, vol. 18, no. 12, 2007, p. 2000, https://doi.org/10.1093/annonc/mdm379.